Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants
- 5 April 2003
- Vol. 41 (6) , 667-678
- https://doi.org/10.1016/s0041-0101(03)00007-2
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Pharmacological modulation of hyperalgesia induced by Bothrops asper (terciopelo) snake venomToxicon, 2001
- Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐1 receptor antagonistBritish Journal of Pharmacology, 2000
- Leucocyte recruitment induced by type II phospholipases A2 into the rat pleural cavityToxicon, 2000
- Inhibition of the myotoxic activity of Bothrops asper myotoxin II in mice by immunization with its synthetic 13-mer peptide 115–129Toxicon, 1999
- Pharmacological modulation of edema induced by Lys-49 and Asp-49 myotoxic phospholipases A2 isolated from the venom of the snake Bothrops asper (terciopelo)Toxicon, 1998
- Immunochemical Characterization and Role in Toxic Activities of Region 115–129 of Myotoxin II, a Lys49 Phospholipase A2fromBothrops asperSnake VenomArchives of Biochemistry and Biophysics, 1998
- Effects of Phospholipase A2 on Lumbar Nerve Root Structure and FunctionSpine, 1997
- Phospholipase A2—a structural reviewToxicon, 1996
- Bradykinin Stimulates Arachidonic Acid Release Through the Sequential Actions of an sn‐1 Diacylglycerol Lipase and a Monoacylglycerol LipaseJournal of Neurochemistry, 1992
- Pharmacological study of phospholipase A2-induced histamine release from rat peritoneal mast cells.Journal of Pharmacobio-Dynamics, 1989